EU-backed metabolic syndrome project has health claim wins in sight

By Shane STARLING contact

- Last updated on GMT

Related tags: European food safety, European union

Nick Henson is the Reading-based associate director at the International Food Network (IFN), a key player in the EU’s new multi-million euro, multi-partner Metabolic Syndrome-battling project, PATHWAY-27, that has health claim victories trained in its sights.

He tells us of the project’s multiple aims that include bridging a perceived gap in data and guidelines to win health claims in the European Union for three selected ingredients: Omega-3 form docosahexaenoic acid (DHA), beta-glucan and anthocyanins.

“A key output is providing a set of guidelines that will potentially help food companies when they are wanting to prepare health claims…this is one of the difficulties that has cropped up in recent times – the difficulty of presenting data to the EFSA [European Food Safety Authority] committee that is effective in generating an approved claim,”​ Henson said.

Market-viable ‘Bioactive-enriched foods (BEF)’ in broad food categories like bakery and dairy are the goal for the 5-year project via a better understanding of the mechanisms of action of the nutrients in question.

IFN will be looking to extend their work at Vitafoods in Geneva, Switzerland, next week.

Partners include the University of Bologna, the French Institut National de la Recherche Agronomique (INRA), the Karolinska Institutet (Sweden), the Max Rubner-Institut (Germany), the VTT Technical Research Centre of Finland, the German Cancer Research Center (DKFZ), the University of Leeds, the University of Southern Denmark, Campden BRI Hungary, the International Life Sciences Institute (ILSI), Lebensmittelversuchsanstalt (Austria), the European Commission Joint Research Centre-Institute for Health and Consumer Protection (IHCP), Giotto Biotech (Italy), NGB Genetics (Italy), Applications Santé des Lipides (France), Abro Biotec (Spain), Swedish Oat Fiber and ADEXGO Ltd (Hungary).

Metabolic syndrome refers to a range of maladies including coronary artery disease, stroke and Type-2 diabetes.

Related news

Show more

Related products

show more

Loading up on carb science

Loading up on carb science

FrieslandCampina Ingredients | 01-Mar-2020 | Technical / White Paper

In a world where everyone seems to be telling consumers to cut back on carbs, from a food industry point of view, there is an education job to be done...

Taking the healthy way, follow The Life Guardian™.

Taking the healthy way, follow The Life Guardian™.

Indena: botanical ingredients for the Health Food industry | 11-Feb-2020 | Technical / White Paper

Meriva® – curcumin Phytosome offers the complete power of all 3 major curcuminoids and its optimized bioabsorpion thanks to Phytosome Indena’s delivery...

NEXT GENERATION CURCUMIN

NEXT GENERATION CURCUMIN

SABINSA | 27-Jan-2020 | Data Sheet

Sabinsa’s patented, colorless, Curcumin C3 Reduct® is 250 times more effective than curcumin in activating AMP Kinase (Intracellular Fuel Gauge). This...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars